Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model.
Respiratory syncytial virus (RSV) infects approximately 90% of young children by the age of 2 yr, with peak rates occurring during 2-6 mo of age. Exposure to side-stream cigarette smoke (SS) may increase the incidence or manifestation of an RSV infection. We hypothesized that exposure to SS would alter the subsequent immune response to RSV infection in neonatal mice. BALB/c mice were exposed to air or 1.5 mg/m3 of SS from day (d) 1 up to 35 d of age. A subset was intranasally infected with 4x10(4) PFU of RSV/g body wt on d 7 and rechallenged at 28 d of age. Immune responses were assessed on d 4 and 7 after RSV rechallenge. Both air- and SS-exposed mice responded to RSV rechallenge with neutrophilia and decreased Clara cell secretory protein levels within the lung. However, an increase in bronchoalveolar lavage fluid eosinophils, in addition to reduced levels of Th1 cytokines (IFN-gamma and IL-12), decreased lung tissue inflammation, and decreased mucus production was observed in SS-exposed mice compared with air-exposed mice after RSV rechallenge. Ultimately changes in cytokine and inflammatory responses due to SS exposure likely contributed to increased viral gene expression. These results suggest that SS exposure plays a significant role in shaping the neonatal response to RSV infection.
Phaybouth
Vatsana
V
Respiratory Immunology and Asthma Program, Lovelace Respiratory Research Inst., 2425 Ridgecrest Dr. SE, Albuquerque, NM 87108, USA.
Wang
Shan-Ze
SZ
Hutt
Julie A
JA
McDonald
Jacob D
JD
Harrod
Kevin S
KS
Barrett
Edward G
EG
D000818:Animals; D000831:Animals, Newborn; D016207:Cytokines / Q000096:biosynthesis*; D004195:Disease Models, Animal; D005260:Female; D018836:Inflammation Mediators / Q000378:metabolism; D007378:Interleukins / Q000096:biosynthesis; D008168:Lung / Q000276:immunology / Q000503:physiopathology; D051379:Mice; D008807:Mice, Inbred BALB C; D009093:Mucus / Q000502:physiology; D011014:Pneumonia / Q000139:chemically induced / Q000473:pathology; D018357:Respiratory Syncytial Virus Infections / Q000503:physiopathology; D012136:Respiratory Syncytial Viruses / Q000378:metabolism; D012906:Smoke / Q000009:adverse effects*; D018417:Th1 Cells / Q000187:drug effects / Q000378:metabolism; D014026:Nicotiana / Q000009:adverse effects; D014598:Uteroglobin / Q000096:biosynthesis; D014764:Viral Proteins / Q000096:biosynthesis
D016207:Cytokines; D018836:Inflammation Mediators; D007378:Interleukins; C556390:Scgb1a1 protein, mouse; D012906:Smoke; D014764:Viral Proteins; D014598:Uteroglobin